Latest News
AT&T Shares Dip Amid Broad Market Gains, Focus Shifts to Key Economic Data
AT&T stock declined 0.7% to $27.13 on Friday, underperforming a broader market rally that pushed the Dow Jones Industrial Average above 50,000. Investors are now awaiting delayed U.S. employment and inflation reports.
Gilead Hits 52-Week Peak on FDA Label Expansion for Yescarta, Earnings in Focus
Gilead Sciences reached a 52-week high after the FDA approved a label update for its Yescarta therapy, expanding use to a rare brain lymphoma. The stock's rally comes ahead of the company's quarterly earnings report.
Abbott Shares Gain on Insider Purchase and Positive Cardiac Device Data
Abbott Laboratories stock rose 1.6% Friday following a director's $1.09 million share purchase and new clinical data for its heart rhythm devices presented at a medical symposium.
Disney Shares Face Regulatory Scrutiny as FCC Probes ABC Talk Show
Walt Disney Co's stock will be monitored Monday after U.S. regulators launched an investigation into ABC's 'The View' regarding election airtime rules. Shares closed Friday at $108.70, up 3.6%.
Texas Instruments Slashes Capex, Eyes Silicon Labs Deal Amid Insider Sales
Texas Instruments shares fell 1.13% as the company plans to cut 2026 capital spending to $2-3 billion and fund its Silicon Labs acquisition with cash and debt. Key executives sold shares after exercising options.
Novo Nordisk Rebounds as FDA Vows Crackdown on Wegovy Copycats
Novo Nordisk B shares surged 5.29% after Hims & Hers halted its $49 compounded version of Wegovy, with the FDA pledging action against unauthorized copycats. The stock remains down roughly 20% over five sessions amid pricing uncertainty.
Linde Shares Face Pressure After JPMorgan Downgrade, Focus Turns to Pricing Outlook
Linde stock fell 2.53% to $448.07 Friday after JPMorgan cut its rating to Neutral, citing valuation and flat sequential pricing. Investors await U.S. jobs data and company conferences this week.
Inditex Initiates Share Repurchase Ahead of March Earnings
Inditex shares edged higher Friday after announcing a €180 million buyback program for employee incentives, with full-year results due March 11.
Thermo Fisher Shares End Week Lower Amid Research Funding Concerns
Thermo Fisher Scientific closed Friday at $542.83, down 6.7% for the week as investors weigh pressure from academic research funding cuts. The company's 2026 outlook projects adjusted earnings of $24.22 to $24.80 per share.
GE Vernova Surges 5.6% as Energy Infrastructure Demand Fuels Rally
GE Vernova shares climbed to $779.35 amid a broader market rally, buoyed by new wind orders and a strategic alliance. Analysts highlight the early-stage energy infrastructure cycle but note wind segment risks.